ECT-001 (UM171)

UM171

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ECT-001 (UM171), covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma [Phase 1, Phase 2]